QUEBEC CITY, February 13, 2025--(BUSINESS WIRE)--Devonian Health Group Inc. ("Devonian" or the "Company") (TSXV: GSD; OTCQB: DVHGF), a clinical stage corporation focused on developing unique solutions ...
NEW YORK, Nov. 17, 2025 (GLOBE NEWSWIRE) -- Raphael Pharmaceutical Inc. (“Raphael Pharmaceutical” or the “Company”) (OTCQB: RAPH), a clinical-stage biotechnology company developing an innovative ...
Continued expansion of IP portfolio related to RNA delivery Treatment of rheumatoid arthritis as one of the key therapeutic indications HAMILTON, BERMUDA / May 1, 2024 / Altamira Therapeutics Ltd.
As part of the effort to harmonize global patent systems, the United States introduced the provisional patent application in 1995 as part of the GATT Uruguay Round agreement. The provisional patent ...
Actinium Pharmaceuticals, Inc. has announced that it has filed a provisional patent application with the United States Patent and Trademark Office (USPTO) pertaining to Iomab-B, the Company's ...
AIM ImmunoTech Announces Filing of Provisional Patent Application for Use of Ampligen as Both an Intranasal and an IV Therapy for Post-COVID-19 Cognitive Dysfunction (PCCD) OCALA, Fla., Aug. 25, 2021 ...
NEW YORK, Nov. 17, 2025 (GLOBE NEWSWIRE) -- Raphael Pharmaceutical Inc. (RAPH), a clinical-stage biotechnology company developing an innovative research platform based on cannabinoids free of THC and ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback